Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Semaglutide TFA is a agonist of glucagon-like peptide-1 (GLP-1) receptor,with a potential for type 2 diabetes treatment. 在相同实验条件下,摩尔浓度相同的化合物盐形式与游离态具有相同的生物活性,但盐形式 Semaglutide Acetate 的水溶性和稳定性通常比游离态更好。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 2,245 | 待询 | ||
5 mg | ¥ 7,770 | 待询 |
Semaglutide TFA (910463-68-2 free base) 的其他形式现货产品:
产品描述 | Semaglutide TFA is a agonist of glucagon-like peptide-1 (GLP-1) receptor,with a potential for type 2 diabetes treatment. |
体外活性 | Semaglutide has two amino acid substitutions compared to human GLP-1 (Aib8, Arg34) and is derivatized at lysine 26. Semaglutide`s GLP-1R affinity is 0.38±0.06 nM[1]. Semaglutide is an analogue of GLP-1 with 94% sequence omology to human GLP-1[3. |
体内活性 | The plasma half-life of Semaglutide is 46h in mini-pigs following i.v. administration and semaglutide has an MRT of 63.6h after s.c. dosing to mini-pigs[1]. 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced motor impairmentsimproved by Semaglutide. In addition, Semaglutide rescues the decrease of tyrosine hydroxylase (TH) levels, reduces lipid peroxidation, alleviates the inflammation response, inhibits the apoptosis pathway and increases autophagy- related protein expression, to protect dopaminergic neurons in the substantia nigra and striatum. Moreover, the long-acting GLP-1 analogue semaglutide is superior to liraglutide in most parameters[2]. Semaglutide lowers blood glucose by stimulating the release of insulin and also lowers body weight[3]. |
别名 | Semaglutide TFA |
分子量 | 4210.63 |
分子式 | NA |
CAS No. | T12878 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (23.75 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 0.2375 mL | 1.1875 mL | 2.3749 mL | 5.9374 mL |
5 mM | 0.0475 mL | 0.2375 mL | 0.475 mL | 1.1875 mL | |
10 mM | 0.0237 mL | 0.1187 mL | 0.2375 mL | 0.5937 mL | |
20 mM | 0.0119 mL | 0.0594 mL | 0.1187 mL | 0.2969 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Semaglutide TFA (910463-68-2 free base) T12878 GPCR/G Protein Glucagon Receptor Semaglutide TFA (910463 68 2 free base) 910463-68-2 Semaglutide TFA (910463682 free base) Semaglutide TFA 910463-68-2 free base Inhibitor inhibitor inhibit